GlassScriptPhysician profile
Shaju Shamsuddin
NPI 1982696878
$1,109.48
in general payments reported to CMS, 2019-2025
14 companies · $207 in 2025
The $207 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $209 · 2020: $29.60 · 2021: $75.60 · 2022: $201 · 2023: $388 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $594.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $594.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $200.12 | 2023-2025 | Imfinzi, Breztri |
| Gilead Sciences, INC. | $119.57 | 2023 | Trodelvy |
| Boston Scientific Corporation | $103.49 | 2019 | |
| Novo Nordisk INC | $100.86 | 2022 | |
| Progenics Pharmaceuticals, INC. | $100.00 | 2022 | |
| Janssen Biotech, INC. | $95.69 | 2023 | Tecvayli, Darzalex, Carvykti |
| Xeris Pharmaceuticals, INC. | $82.68 | 2025 | Gvoke Hypopen |
| Abbvie INC. | $75.60 | 2021 | |
| Glaxosmithkline, LLC. | $71.62 | 2023 | Arexvy |
| Siemens Medical Solutions USA, INC. | $58.64 | 2019-2020 | |
| Varian Medical Systems, INC. | $47.79 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.56 | 2025 | |
| Brainlab, INC. | $16.66 | 2019 | |
| Fortovia Therapeutics, INC. | $12.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shaju Shamsuddin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.